X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Astec Lifesciences Ltd.
BSE CODE: 533138   |   NSE CODE: ASTEC   |   ISIN CODE : INE563J01010   |   14-Aug-2025 Hrs IST
BSE NSE
Rs. 812.80
10.1 ( 1.26% )
 
Prev Close ( Rs.)
802.70
Open ( Rs.)
800.05
 
High ( Rs.)
870.50
Low ( Rs.)
796.10
 
Volume
13954
Week Avg.Volume
4733
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 810.15
9.8 ( 1.22% )
 
Prev Close ( Rs.)
800.35
Open ( Rs.)
804.00
 
High ( Rs.)
872.00
Low ( Rs.)
795.45
 
Volume
429511
Week Avg.Volume
116473
 
52 WK High-Low Range(Rs.)
629.78
1323.38
Particulars Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Operational & Financial Ratios          
   Earnings Per Share (Rs)-68.74  -23.96  13.02  45.83  33.03  
   CEPS(Rs)-46.08  -5.40  29.99  62.93  45.82  
   DPS(Rs)0.00  0.00  1.50  1.50  1.50  
   Book NAV/Share(Rs)119.30  187.82  213.43  201.91  157.39  
   Tax Rate(%)4.47  24.06  26.77  25.80  27.04  
Margin Ratios          
   Core EBITDA Margin(%)-17.00  -1.29  12.08  22.66  19.94  
   EBIT Margin(%)-26.82  -7.98  8.81  19.14  16.73  
   Pre Tax Margin(%)-36.24  -13.47  5.52  17.80  15.87  
   PAT Margin (%)-34.62  -10.23  4.04  13.21  11.58  
   Cash Profit Margin (%)-23.38  -2.32  9.38  18.27  16.18  
Performance Ratios          
   ROA(%)-14.50  -4.81  2.68  11.20  10.35  
   ROE(%)-44.77  -11.94  6.27  25.52  23.35  
   ROCE(%)-12.65  -4.52  7.75  22.22  22.22  
   Asset Turnover(x)0.42  0.47  0.66  0.85  0.89  
   Sales/Fixed Asset(x)0.58  0.85  1.31  1.71  1.90  
   Working Capital/Sales(x)-15.14  1981.30  -22.36  27.96  74.91  
Efficiency Ratios          
   Fixed Capital/Sales(x)1.72  1.18  0.76  0.58  0.52  
   Receivable days148.32  128.71  123.89  123.70  113.65  
   Inventory Days166.70  194.99  139.29  78.67  74.22  
   Payable days105.02  152.35  167.15  150.54  176.97  
Valuation Parameters          
   PER(x)0.00  0.00  106.21  38.24  30.29  
   PCE(x)-14.54  -195.11  45.76  27.64  21.67  
   Price/Book(x)5.66  5.65  6.48  8.68  6.36  
   Yield(%)0.00  0.00  0.11  0.09  0.15  
   EV/Net Sales(x)4.92  5.62  4.86  5.49  3.87  
   EV/Core EBITDA(x)-30.95  -8069.87  34.16  22.56  18.00  
   EV/EBIT(x)-17.97  -70.30  54.87  28.52  22.95  
   EV/CE(x)2.38  2.99  4.01  5.50  4.33  
   M Cap / Sales3.47  4.55  4.31  5.08  3.53  
Growth Ratio          
   Net Sales Growth(%)-16.78  -27.06  -7.15  21.93  6.25  
   Core EBITDA Growth(%)0.00  -100.36  -45.73  38.07  22.69  
   EBIT Growth(%)-185.03  -165.90  -57.28  39.23  26.45  
   PAT Growth(%)-186.90  -284.12  -71.59  38.84  36.28  
   EPS Growth(%)-186.87  -284.08  -71.60  38.77  36.14  
Financial Stability Ratios          
   Total Debt/Equity(x)2.37  1.34  0.82  0.71  0.61  
   Current Ratio(x)0.93  1.00  0.95  1.05  1.02  
   Quick Ratio(x)0.49  0.51  0.39  0.67  0.69  
   Interest Cover(x)-2.84  -1.45  2.68  14.32  19.51  
   Total Debt/Mcap(x)0.42  0.24  0.13  0.08  0.10